SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018842
Filing Date
2023-11-13
Accepted
2023-11-13 16:29:02
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20230930x10q.htm   iXBRL 10-Q 1332134
2 EX-10.2 nrbo-20230930xex10d2.htm EX-10.2 315583
3 EX-31.1 nrbo-20230930xex31d1.htm EX-31.1 16930
4 EX-31.2 nrbo-20230930xex31d2.htm EX-31.2 16936
5 EX-32.1 nrbo-20230930xex32d1.htm EX-32.1 10725
6 EX-32.2 nrbo-20230930xex32d2.htm EX-32.2 10545
7 GRAPHIC nrbo-20230930xex10d2001.jpg GRAPHIC 3355
  Complete submission text file 0001558370-23-018842.txt   6404166

Data Files

Seq Description Document Type Size
8 EX-101.SCH nrbo-20230930.xsd EX-101.SCH 46522
9 EX-101.CAL nrbo-20230930_cal.xml EX-101.CAL 35107
10 EX-101.DEF nrbo-20230930_def.xml EX-101.DEF 191443
11 EX-101.LAB nrbo-20230930_lab.xml EX-101.LAB 405956
12 EX-101.PRE nrbo-20230930_pre.xml EX-101.PRE 307848
65 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20230930x10q_htm.xml XML 1013987
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 231399264
SIC: 2834 Pharmaceutical Preparations